Sartorius Stedim BioOutsource Competitors and Similar CompaniesClear all
Sartorius Stedim BioOutsource's competitors and similar companies include Advarra, Cipla, UCB and Livzon Pharmaceutical Group.
 Sartorius Stedim BioOutsource Sartorius Stedim BioOutsource is a provider of contract testing services to the biopharmaceutical and biotechnology industries. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2007 | Founding Date 1983 | Founding Date 1935 | Founding Date 1928 | Founding Date 1985 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Glasgow, GB HQ | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | |
Employees | Employees 1281% decrease | Employees 1,7311% increase | Employees 27,764 | Employees 9,052 | Employees 9,067 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.3 b | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) £9m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods £7.2m (FY, 2018) | Cost of goods N/A | Cost of goods ₹95.5b (FY, 2026) | Cost of goods €1.4b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit £1.7m (FY, 2018) | Gross profit N/A | Gross profit ₹195b (FY, 2026) | Gross profit €7.2b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income (£3.7m) (FY, 2018) | Net income N/A | Net income ₹38.7b (FY, 2026) | Net income €1.6b (FY, 2025) | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Advarra
HQ
Columbia, US
Employees
1,731↑ 1% increase
Advarra is a company that develops clinical research software.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company